Cargando…

The In Vitro Stability of Circulating Tumour DNA

OBJECTIVE: DNA from apoptotic cancer cells, present in the circulation, has the potential to facilitate genomic profiling and disease monitoring. However, only low fractions of total cell-free DNA originates from cancer cells, limiting the applicability of circulating tumour DNA (ctDNA). Optimal sam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henao Diaz, Emanuela, Yachnin, Jeffrey, Grönberg, Henrik, Lindberg, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154581/ https://www.ncbi.nlm.nih.gov/pubmed/27959945 http://dx.doi.org/10.1371/journal.pone.0168153

Ejemplares similares

Unimpeded Growth of Tumour in Hosts Pre-immunized with Tyrosyl- or Dinitrophenyl-coated Tumour Cells
por: Bauminger, Sara, et al.
Publicado: (1972)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
por: Sivapalan, Lavanya, et al.
Publicado: (2022)

Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization
por: Renaud, Gabriel, et al.
Publicado: (2022)

High Fragmentation Characterizes Tumour-Derived Circulating DNA
por: Mouliere, Florent, et al.
Publicado: (2011)

Circulating tumour DNA — looking beyond the blood
por: Tivey, Ann, et al.
Publicado: (2022)

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
por: McEvoy, Ashleigh C., et al.
Publicado: (2018)

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy
por: Wahl, Sissel Gyrid Freim, et al.
Publicado: (2021)

Circulating tumour DNA analysis in multiple myeloma
por: Mithraprabhu, Sridurga, et al.
Publicado: (2017)

Circulating Tumour DNA in Melanoma—Clinic Ready?
por: Tivey, Ann, et al.
Publicado: (2022)

Circulating tumour DNA in colorectal cancer management
por: Cohen, Ryan, et al.
Publicado: (2023)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

Determining breast cancer histological grade from RNA-sequencing data
por: Wang, Mei, et al.
Publicado: (2016)

Detection of metastases using circulating tumour DNA in uveal melanoma
por: Beasley, Aaron B., et al.
Publicado: (2023)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019
por: Christou, Niki, et al.
Publicado: (2019)

Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2022)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Circulating tumour-derived DNA in metastatic soft tissue sarcoma
por: Eastley, Nicholas C., et al.
Publicado: (2018)

Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non‐small‐cell lung cancer treated with pembrolizumab
por: Mondelo‐Macía, Patricia, et al.
Publicado: (2021)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

Circulating Cell-Free Tumour DNA in the Management of Cancer
por: Francis, Glenn, et al.
Publicado: (2015)

Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
por: Tan, Melissa P., et al.
Publicado: (2018)

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma
por: Loft, Matthew, et al.
Publicado: (2019)

Development of circulating tumour DNA analysis for gastrointestinal cancers
por: Nakamura, Yoshiaki, et al.
Publicado: (2020)

Intra‐individual variation of circulating tumour DNA in lung cancer patients
por: Hojbjerg, Johanne A., et al.
Publicado: (2019)

Genomic profile of advanced breast cancer in circulating tumour DNA
por: Kingston, Belinda, et al.
Publicado: (2021)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma
por: Escudero, Laura, et al.
Publicado: (2020)

Library Preparation and Multiplex Capture for Massive Parallel Sequencing Applications Made Efficient and Easy
por: Neiman, Mårten, et al.
Publicado: (2012)

Plasma Epstein–Barr virus DNA as an archetypal circulating tumour DNA marker
por: Lam, Wai Kei Jacky, et al.
Publicado: (2019)

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencing
por: Kleftogiannis, Dimitrios, et al.
Publicado: (2020)

Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation
por: Skvortsova, T E, et al.
Publicado: (2006)

Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample
por: Rothwell, Dominic G., et al.
Publicado: (2015)

Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study
por: Palsdottir, Thorgerdur, et al.
Publicado: (2019)

Development and Validation of a Novel RNA Sequencing–Based Prognostic Score for Acute Myeloid Leukemia
por: Wang, Mei, et al.
Publicado: (2018)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
por: Keppens, Cleo, et al.
Publicado: (2018)

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
por: Wu, Huanwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q0il87k25vieqqm3enfikq13fq